BACKGROUND: A single prospective randomized study found that, in selected patients with acute respiratory failure (ARF) followinglung resection, noninvasive ventilation (NIV) decreases the need for endotracheal mechanical ventilation and improves clinical outcome. METHOD: We prospectively evaluated early NIV use for ARF after lung resection during a 4-year period in the setting of a medical and a surgical ICU of a university hospital. We documented demographics, initial clinical characteristics and clinical outcomes. NIV failure was defined as the need for tracheal intubation. RESULTS: Among 690 patients at risk ofsevere complications following lung resection, 113 (16.3%) experienced ARF, which was initially supported by NIV in 89 (78.7%), including 59 with hypoxemic ARF (66.3%) and 30 with hypercapnic ARF (33.7%). The overall success rate of NIV was 85.3% (76/89). In-ICU mortality was 6.7% (6/89). The mortality rate following NIV failure was 46.1%. Predictive factors of NIV failure in univariate analysis were age (P = 0.046), previous cardiac comorbidities (P = 0.0075), postoperative pneumonia (P = 0.0016), admission in the surgical ICU (P = 0.034), no initial response to NIV (P < 0.0001) and occurrence of noninfectious complications (P = 0.037). Only two independent factors were significantly associated with NIV failure in multivariate analysis: cardiac comorbidities (odds ratio, 11.5; 95% confidence interval, 1.9-68.3; P = 0.007) and no initial response to NIV (odds ratio, 117.6; 95% confidence interval, 10.6-1305.8; P = 0.0001). CONCLUSION: This prospective survey confirms the feasibility and efficacy of NIV in ARF following lung resection.
RCT Entities:
BACKGROUND: A single prospective randomized study found that, in selected patients with acute respiratory failure (ARF) following lung resection, noninvasive ventilation (NIV) decreases the need for endotracheal mechanical ventilation and improves clinical outcome. METHOD: We prospectively evaluated early NIV use for ARF after lung resection during a 4-year period in the setting of a medical and a surgical ICU of a university hospital. We documented demographics, initial clinical characteristics and clinical outcomes. NIV failure was defined as the need for tracheal intubation. RESULTS: Among 690 patients at risk of severe complications following lung resection, 113 (16.3%) experienced ARF, which was initially supported by NIV in 89 (78.7%), including 59 with hypoxemic ARF (66.3%) and 30 with hypercapnic ARF (33.7%). The overall success rate of NIV was 85.3% (76/89). In-ICU mortality was 6.7% (6/89). The mortality rate following NIV failure was 46.1%. Predictive factors of NIV failure in univariate analysis were age (P = 0.046), previous cardiac comorbidities (P = 0.0075), postoperative pneumonia (P = 0.0016), admission in the surgical ICU (P = 0.034), no initial response to NIV (P < 0.0001) and occurrence of noninfectious complications (P = 0.037). Only two independent factors were significantly associated with NIV failure in multivariate analysis: cardiac comorbidities (odds ratio, 11.5; 95% confidence interval, 1.9-68.3; P = 0.007) and no initial response to NIV (odds ratio, 117.6; 95% confidence interval, 10.6-1305.8; P = 0.0001). CONCLUSION: This prospective survey confirms the feasibility and efficacy of NIV in ARF following lung resection.
Authors: I Auriant; A Jallot; P Hervé; J Cerrina; F Le Roy Ladurie; J L Fournier; B Lescot; F Parquin Journal: Am J Respir Crit Care Med Date: 2001-10-01 Impact factor: 21.405
Authors: Raffaele Scala; Sandra Bartolucci; Mario Naldi; Marcello Rossi; Mark W Elliott Journal: Intensive Care Med Date: 2004-07-17 Impact factor: 17.440
Authors: Christophe Girault; Anca Briel; Marie-France Hellot; Fabienne Tamion; Dominique Woinet; Jacques Leroy; Guy Bonmarchand Journal: Crit Care Med Date: 2003-02 Impact factor: 7.598
Authors: Francisco Javier Algar; Antonio Alvarez; Angel Salvatierra; Carlos Baamonde; José Luis Aranda; Francisco Javier López-Pujol Journal: Eur J Cardiothorac Surg Date: 2003-02 Impact factor: 4.191
Authors: Adeline Fraisse; Sophie Brosse; Patrick Manckoundia; Laura Popitéan; Pierre Pfitzenmeyer Journal: Presse Med Date: 2003-10-04 Impact factor: 1.228
Authors: Anke Kohlenberg; Frank Schwab; Michael Behnke; Christine Geffers; Petra Gastmeier Journal: Intensive Care Med Date: 2010-03-23 Impact factor: 17.440
Authors: Massimo Antonelli; Elie Azoulay; Marc Bonten; Jean Chastre; Giuseppe Citerio; Giorgio Conti; Daniel De Backer; François Lemaire; Herwig Gerlach; Goran Hedenstierna; Michael Joannidis; Duncan Macrae; Jordi Mancebo; Salvatore M Maggiore; Alexandre Mebazaa; Jean-Charles Preiser; Jerôme Pugin; Jan Wernerman; Haibo Zhang Journal: Intensive Care Med Date: 2010-02-23 Impact factor: 17.440
Authors: N N M Razafimanjato; J M Rakotoson; M Ravoatrarilandy; R L Andrianasolo; A T Rajaonera; N E Raveloson; H J L Rakotovao Journal: Med Trop Sante Int Date: 2021-02-18
Authors: Christine Lorut; Aurélie Lefebvre; Benjamin Planquette; Laurent Quinquis; Hervé Clavier; Nicola Santelmo; Halim Abou Hanna; François Bellenot; Jean-François Regnard; Marc Riquet; Pierre Magdeleinat; Guy Meyer; Nicolas Roche; Gérard Huchon; Joel Coste; Antoine Rabbat Journal: Intensive Care Med Date: 2013-11-29 Impact factor: 17.440